학술논문
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, In Press, 28 October 2014) 7p.
Subject
Language
English
ISSN
14320584
09395555
09395555